Stay updated on Viatris Press Releases
Sign up to get notified when there's something new on the Viatris Press Releases page.

Latest updates to the Viatris Press Releases page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedAdded a new press release on Mar 23, 2026 about Effexor® approval in Japan for adults with GAD; removed the Dec 17, 2025 press release about presenting at the JP Morgan Healthcare Conference.SummaryDifference7%

- Check16 days agoChange DetectedA new press release entry dated Mar 19, 2026 was added to the Press Releases page; an older release about monetizing its Biocon Biologics stake was removed.SummaryDifference7%

- Check23 days agoNo Change Detected
- Check37 days agoChange DetectedNew press releases were added for Feb 26, 2026: Viatris’ Fourth-Quarter and Full-Year 2025 Financial Results and the Dividend Policy for 2026; and Feb 25, 2026: FDA accepts the NDA for MR-141. Older November 2025 press releases were removed from the list.SummaryDifference8%

- Check59 days agoChange DetectedTwo new press releases were added: Viatris to Report Fourth Quarter and Full Year 2025 Financial Results on February 26, 2026, and Viatris Appoints Matthew J. Maletta as Chief Legal Officer. Two older items were removed: Viatris Announces Quarterly Dividend and Viatris Completes Acquisition of Aculys Pharma Including Exclusive Rights to Pitolisant in Japan and to Spydia® in Japan and Certain Other Markets in the Asia-Pacific Region.SummaryDifference7%

- Check74 days agoChange DetectedA new press release on Jan 20, 2026 about Inpefa launch was added; the Oct 13, 2025 entry was removed.SummaryDifference7%

- Check81 days agoChange DetectedA new press release item dated Jan 8, 2026 announces Lara Ramsburg as Chief People and Corporate Affairs Officer added to the Viatris press releases page.SummaryDifference7%

Stay in the know with updates to Viatris Press Releases
Enter your email address, and we'll notify you when there's something new on the Viatris Press Releases page.